Study of TRM-1(TRAIL-R1 Monoclonal Antibody) in Subjects With Relapsed or Refractory Non-Small Cell Lung Cancer (NSCLC)
Clinical trial NCT00092924 · COMPLETED
Trial details
- NCT number
- NCT00092924
- Sponsor
- Human Genome Sciences Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Primary completion
- 2005-01-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.